Eagle Point Credit Company Inc. 6.50% Series C Term Preferred Stock due 2031 (ECCC)
StalwartFairStock Score: 56/100 — STEADY
Key Financials
| Current Price | $24.32 |
| Market Cap | — |
| P/E Ratio | 13.36 |
| ROE | -18.07% |
| Dividend Yield | 6.59% |
| Sector | Financial Services |
Strengths
- Conservative balance sheet with debt-to-equity of just 0.40, providing financial flexibility
- Attractive 6.6% dividend yield providing steady income returns
Concerns
- Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
- Weak Piotroski F-Score of 1/9 suggests deteriorating financial quality across multiple dimensions
AI Analysis
Eagle Point Credit Company Inc. 6.50% Series C Term Preferred Stock due 2031 is a micro-cap financial services company. Revenue stands at $204 million, though the company is currently unprofitable. From a quality standpoint, Eagle shows weak Piotroski F-Score of 1/9 signaling deteriorating fundamentals and negative ROE indicating losses. On valuation, the stock is attractively valued at 13.6x earnings, with trades above its Graham Number with a negative 30% margin. The 6.6% dividend yield adds an income component for patient holders. Our composite FairStock Score of 56/100 reflects mixed fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.
Bull Case
Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.
Bear Case
Without a clear path to profitability, continued cash burn forces either dilutive equity raises or debt accumulation that destroys shareholder value. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer